Development and pilot testing of the revised Patients’ Attitudes Towards Deprescribing questionnaire for people with cognitive impairment
Access status:
Open Access
Type
ArticleAuthor/s
Reeve, EmilyAnthony, AC
Kouladjian O'Donnell, Lisa
Low, Lee-Fay
Ogle, SJ
Glendenning, JE
Lorang, CE
Hilmer, Sarah N
Abstract
Objectives: 1) To develop a version of the revised Patients’ Attitude Towards Deprescribing (rPATD) questionnaire for people with mild cognitive impairment and mild-to-moderate dementia (rPATDcog) and 2) capture the beliefs and attitudes of this population and their carers about ...
See moreObjectives: 1) To develop a version of the revised Patients’ Attitude Towards Deprescribing (rPATD) questionnaire for people with mild cognitive impairment and mild-to-moderate dementia (rPATDcog) and 2) capture the beliefs and attitudes of this population and their carers about deprescribing through a pilot study. Methods: Firstly, the rPATDcog was modified from the rPATD and tested in a small group of participants with mild cognitive impairment, then we conducted a pilot study of the rPATDcog and the carers’ rPATD. Results: Twenty-one participants with cognitive impairment and 11 carer participants (forming dyads) participated in this study. Eighty-one percent (17/21) of participants said that they would stop one or more of their medications if their doctor said it was possible. There was excellent agreement of corresponding questions between dyads. Conclusions: The rPATDcog was feasible to administer in this study. Further work is required to provide generalisable results and determine utility in practice.
See less
See moreObjectives: 1) To develop a version of the revised Patients’ Attitude Towards Deprescribing (rPATD) questionnaire for people with mild cognitive impairment and mild-to-moderate dementia (rPATDcog) and 2) capture the beliefs and attitudes of this population and their carers about deprescribing through a pilot study. Methods: Firstly, the rPATDcog was modified from the rPATD and tested in a small group of participants with mild cognitive impairment, then we conducted a pilot study of the rPATDcog and the carers’ rPATD. Results: Twenty-one participants with cognitive impairment and 11 carer participants (forming dyads) participated in this study. Eighty-one percent (17/21) of participants said that they would stop one or more of their medications if their doctor said it was possible. There was excellent agreement of corresponding questions between dyads. Conclusions: The rPATDcog was feasible to administer in this study. Further work is required to provide generalisable results and determine utility in practice.
See less
Date
2018-01-01Source title
Australasian Journal on AgeingVolume
37Issue
4Publisher
WileyLicence
Copyright All Rights ReservedFaculty/School
Faculty of Medicine and HealthShare